Theranos Bleeds out...

Posted by Sten Westgard, MS

Well the horn is off the unicorn. (A unicorn, in Silicon Valley parlance, is a startup with a billion dollar valuation). In the wake of a presentation at the AACC/ASCLS annual conference that was almost universally panned, Theranos continued its downward slide, until in October it pulled the plug on its direct laboratory testing business. Now it is "refocusing" on developing its new MiniLab, a smaller POC device that seems far less revolutionary than the lofty claims once put forth. If Theranos is just another POC device company, it's overvalued.

For some analytical analysis of the first performance claimed by the MiniLab, check out this LinkedIn post (subscription required).

Also, I recommend this article from WSJ: Dubious test results from Theranos hurt patients, and some didn't get corrected results for months https://lnkd.in/bu9er7N If you read carefully, you might see someone familiar get quoted...